当前位置:首页 - 行情中心 - 葵花药业(002737) - 财务分析 - 现金流量表

葵花药业

(002737)

  

流通市值:85.26亿  总市值:85.26亿
流通股本:5.84亿   总股本:5.84亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,558,594,617.291,414,883,507.64669,167,2113,118,007,102
  收到其他与经营活动有关的现金128,347,590.4889,936,111.6371,577,160.24190,596,466.27
  经营活动现金流入小计1,686,942,207.771,504,819,619.27740,744,371.243,308,603,568.27
  购买商品、接受劳务支付的现金420,794,433.08303,416,496.29183,014,710.351,608,333,305.42
  支付给职工以及为职工支付的现金440,849,607.04306,103,795.97146,741,402.57646,219,449.65
  支付的各项税费171,412,976.09121,141,337.0887,326,774.04459,288,521.45
  支付其他与经营活动有关的现金433,561,199.36424,535,605.51221,950,914.77902,242,428.98
  经营活动现金流出小计1,466,618,215.571,155,197,234.85639,033,801.733,616,083,705.5
  经营活动产生的现金流量净额220,323,992.2349,622,384.42101,710,569.51-307,480,137.23
二、投资活动产生的现金流量:
  收回投资收到的现金8,119,116,312.915,617,543,0111,554,983,0114,890,526,609
  取得投资收益收到的现金31,198,234.4419,865,775.2311,821,725.2334,471,884.06
  处置固定资产、无形资产和其他长期资产收回的现金净额191,87627,168-328,042
  投资活动现金流入小计8,150,506,423.355,637,435,954.231,566,804,736.234,925,326,535.06
  购建固定资产、无形资产和其他长期资产支付的现金67,421,423.121,388,737.017,091,626.0992,789,129.31
  投资支付的现金8,360,000,0005,560,000,0001,760,000,0004,830,000,000
  投资活动现金流出小计8,427,421,423.15,581,388,737.011,767,091,626.094,922,789,129.31
  投资活动产生的现金流量净额-276,914,999.7556,047,217.22-200,286,889.862,537,405.75
三、筹资活动产生的现金流量:
  取得借款收到的现金18,000,000---
  收到其他与筹资活动有关的现金---22,093.47
  筹资活动现金流入平衡项目0--0
  筹资活动现金流入小计18,000,000--22,093.47
  偿还债务支付的现金---10,000,000
  分配股利、利润或偿付利息支付的现金310,506,399.09--925,830,458.58
  其中:子公司支付给少数股东的股利、利润18,947,768.05--40,631,072.2
  支付其他与筹资活动有关的现金3,501,536.722,268,340.771,635,144.826,698,042.21
  筹资活动现金流出小计314,007,935.812,268,340.771,635,144.82942,528,500.79
  筹资活动产生的现金流量净额-296,007,935.81-2,268,340.77-1,635,144.82-942,506,407.32
四、汇率变动对现金及现金等价物的影响65,213.33137,250.34-19,109.62-295,368.58
五、现金及现金等价物净增加额-352,533,730.03403,538,511.21-100,230,574.79-1,247,744,507.38
  加:期初现金及现金等价物余额1,037,960,698.511,037,960,698.511,037,960,698.512,285,705,205.89
  期末现金及现金等价物余额685,426,968.481,441,499,209.72937,730,123.721,037,960,698.51
补充资料:
  净利润-81,569,934.45-502,731,508.3
  资产减值准备-7,523,637.63-62,809,452.67
  固定资产和投资性房地产折旧-71,317,619.15-147,403,484.51
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-71,317,619.15-147,403,484.51
  无形资产摊销-13,057,358.11-27,483,070.56
  长期待摊费用摊销-2,157,363-3,606,086.52
  处置固定资产、无形资产和其他长期资产的损失-653,722.6-240,150.99
  固定资产报废损失---4,012,514.75
  公允价值变动损失--5,812,389.88-12,985,379.3
  财务费用-794,028.38-3,510,443.37
  投资损失--10,371,400.62--24,931,696.6
  递延所得税--280,047.2-18,645,038.66
  其中:递延所得税资产减少-747,793.51-21,301,353.83
    递延所得税负债增加--1,027,840.71--2,656,315.17
  存货的减少-119,542,113.73--25,487,853.21
  经营性应收项目的减少-246,443,621.92--415,024,535.63
  经营性应付项目的增加--179,116,141.61--634,383,091.1
  其他---2,769,762.08
  现金的期末余额-1,441,499,209.72-1,037,960,698.51
  减:现金的期初余额-1,037,960,698.51-2,285,705,205.89
  现金及现金等价物的净增加额-403,538,511.21--1,247,744,507.38
公告日期2025-10-282025-08-282025-04-252025-04-25
审计意见(境内)标准无保留意见
TOP↑